Schorr Kathrin, Chen Xinyu, Sasaki Takanori, Arias-Loza Anahi Paula, Lang Johannes, Higuchi Takahiro, Goepferich Achim
Department of Pharmaceutical Technology, University of Regensburg, Regensburg, Bavaria 93053, Germany.
Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Bavaria 86156, Germany.
ACS Pharmacol Transl Sci. 2024 Aug 30;7(9):2604-2611. doi: 10.1021/acsptsci.4c00383. eCollection 2024 Sep 13.
Thin-layer chromatography (TLC) is commonly employed to screen technetium-99m labeled polymer nanoparticle batches for unreduced pertechnetate and radio-colloidal impurities. Although this method is widely accepted, our findings applying radiolabeled PLGA/PLA-PEG nanoparticles underscore its lack of transferability between different settings and its limitations as a standalone quality control tool. While TLC profiles may appear similar for purified and radiocolloid containing nanoparticle formulations, their in vivo behavior can vary significantly, as demonstrated by discrepancies between TLC results and single-photon emission computed tomography (SPECT) and biodistribution data. This highlights the urgent need for a case-by-case evaluation of TLC methods for each specific nanoparticle type. Our study revealed that polymeric nanoparticles cannot be considered analytically uniform entities in the context of TLC analysis, emphasizing the complex interplay between nanoparticle composition, radiolabeling conditions, and subsequent biological behavior.
薄层色谱法(TLC)通常用于筛选99m锝标记的聚合物纳米颗粒批次中的高锝酸盐和放射性胶体杂质。尽管这种方法被广泛接受,但我们应用放射性标记的聚乳酸-羟基乙酸共聚物/聚乳酸-聚乙二醇(PLGA/PLA-PEG)纳米颗粒的研究结果强调了其在不同环境之间缺乏可转移性,以及作为独立质量控制工具的局限性。虽然纯化的和含有放射性胶体的纳米颗粒制剂的TLC图谱可能看起来相似,但它们在体内的行为可能有显著差异,TLC结果与单光子发射计算机断层扫描(SPECT)和生物分布数据之间的差异就证明了这一点。这突出表明迫切需要针对每种特定类型的纳米颗粒对TLC方法进行逐案评估。我们的研究表明,在TLC分析的背景下,聚合物纳米颗粒不能被视为分析上均匀的实体,这强调了纳米颗粒组成、放射性标记条件和随后的生物学行为之间复杂的相互作用。